‘Impressive’ Outcomes Sans Chemo in Downhearted-Prognosis ALL

‘Impressive’ Outcomes Sans Chemo in Downhearted-Prognosis ALL

Uncategorized

Chemo-free targeted therapy yielded excessive charges of molecular response, “impressive” survival at 18 months with few toxic effects in a share 2 trial of adults with Ph+ acute lymphoblastic leukemia (ALL). Medscape Clinical Info
Learn Extra

Leave a Reply

Your email address will not be published. Required fields are marked *